hydralazine has been researched along with isosorbide in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (40.00) | 18.7374 |
1990's | 3 (30.00) | 18.2507 |
2000's | 3 (30.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Iturriaga, J; Lanas, F; Opazo, JA; Saavedra, J; Salvatici, R | 1 |
Bashir, Y; Camm, AJ; Gibson, S; O'Nunain, S; Paul, VE; Sneddon, JF; Ward, DE | 1 |
Bjornson, DC; Daniels, CE; Litman, TJ; Rector, TS; Snowdon, DA; Wertheimer, AI | 1 |
Evans, DB; Harris, AL; Lemp, BM; Silver, PJ | 1 |
Mellow, MH | 1 |
Haughom, F; Kramer, B; Massie, BM | 1 |
King, D | 1 |
Drazner, MH; Wallace, TW | 1 |
Branca, MA | 1 |
Vivian, EM | 1 |
2 review(s) available for hydralazine and isosorbide
Article | Year |
---|---|
Diagnosis and management of heart failure in the elderly.
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Cardiotonic Agents; Digoxin; Diuretics; Female; Heart Failure; Humans; Hydralazine; Isosorbide; Male; Middle Aged; Prognosis; Vasodilator Agents | 1996 |
The impact of race on response to RAAS inhibition.
Topics: Angiotensin-Converting Enzyme Inhibitors; Black People; Clinical Trials as Topic; Diuretics, Osmotic; Drug Therapy, Combination; Enalapril; Heart Failure; Humans; Hydralazine; Isosorbide; Vasodilator Agents; Ventricular Dysfunction, Left; White People | 2005 |
1 trial(s) available for hydralazine and isosorbide
Article | Year |
---|---|
Comparative electrophysiological effects of captopril or hydralazine combined with nitrate in patients with left ventricular dysfunction and inducible ventricular tachycardia.
Topics: Aged; Captopril; Drug Combinations; Electrocardiography; Electrophysiology; Female; Heart; Hemodynamics; Humans; Hydralazine; Isosorbide; Male; Middle Aged; Tachycardia; Ventricular Function, Left | 1992 |
7 other study(ies) available for hydralazine and isosorbide
Article | Year |
---|---|
[Treatment of advanced heart failure with hydralazine and isosorbide dinitrate (author's transl)].
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Drug Therapy, Combination; Female; Heart Failure; Humans; Hydralazine; Isosorbide; Isosorbide Dinitrate; Male; Middle Aged | 1979 |
Impact of a drug-use review program intervention on prescribing after publication of a randomized clinical trial.
Topics: Attitude of Health Personnel; Drug Prescriptions; Drug Utilization; Heart Failure; Hospitals, Veterans; Humans; Hydralazine; Information Theory; Isosorbide; Practice Patterns, Physicians'; Prazosin; Randomized Controlled Trials as Topic; Surveys and Questionnaires; United States | 1990 |
The vasorelaxant effects of milrinone and other vasodilators are attenuated by ouabain.
Topics: Animals; Aorta, Thoracic; Colforsin; Drug Interactions; Female; Guinea Pigs; Hydralazine; In Vitro Techniques; Isoproterenol; Isoquinolines; Isosorbide; Milrinone; Nitroprusside; Ouabain; Pyridones; Sodium-Potassium-Exchanging ATPase; Sulfonamides; Vasodilator Agents; Verapamil | 1988 |
Effect of isosorbide and hydralazine in painful primary esophageal motility disorders.
Topics: Adult; Aged; Bethanechol; Bethanechol Compounds; Deglutition Disorders; Esophageal Diseases; Esophagus; Female; Humans; Hydralazine; Isosorbide; Male; Manometry; Middle Aged; Muscle Contraction; Muscle, Smooth; Sorbitol | 1982 |
Acute and long-term effects of vasodilator therapy on resting and exercise hemodynamics and exercise tolerance.
Topics: Acute Disease; Adult; Aged; Blood Pressure; Exercise Test; Heart Failure; Heart Rate; Hemodynamics; Humans; Hydralazine; Isosorbide; Long-Term Care; Middle Aged; Oxygen Consumption; Rest; Time Factors; Vasodilator Agents | 1981 |
BiDil raises questions about race as a marker.
Topics: Biomarkers; Black People; Clinical Trials as Topic; Dihydropyrimidine Dehydrogenase Deficiency; Dihydrouracil Dehydrogenase (NADP); Drug Approval; Drug Combinations; Drug Interactions; ErbB Receptors; Erlotinib Hydrochloride; Fluorouracil; Gefitinib; Heart Failure; Humans; Hydralazine; Isosorbide; Middle Aged; Mutation; National Institutes of Health (U.S.); Polymorphism, Genetic; Quinazolines; Risk Factors; Socioeconomic Factors; Treatment Outcome; United States; Uracil; White People | 2005 |
Should drug therapy be personalized based on race?
Topics: Antihypertensive Agents; Black or African American; Diuretics; Drug Therapy; Ethnicity; Heart Failure; Humans; Hydralazine; Isosorbide; Minority Groups; Racial Groups; United States; White People | 2006 |